GlassScriptPhysician profile
Omar G Awar
NPI 1154561876
$9,162.60
in general payments reported to CMS, 2019-2025
46 companies · $1,335 in 2025
The $1,335 reported for 2025 was more than what 76% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $799 · 2020: $929 · 2021: $1,435 · 2022: $1,897 · 2023: $1,071 · 2024: $1,697 · 2025: $1,335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,073 · Education: $28.93.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,073.17 |
| Education | $28.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,474.09 | 2019-2025 | |
| Amgen INC. | $790.61 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $739.88 | 2020-2025 | Cardiomems |
| Boehringer Ingelheim Pharmaceuticals, INC. | $696.21 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $671.19 | 2021-2025 | Verquvo, Capvaxive |
| Janssen Pharmaceuticals, INC | $464.79 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $440.81 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Watchman Flx, Varithena Administration Pack |
| Shockwave Medical, INC | $364.25 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $323.81 | 2020-2025 | Wainua, Farxiga |
| Impulse Dynamics (USA) INC. | $313.47 | 2022-2024 | Optimizer |
| Medtronic, INC. | $220.92 | 2022-2024 | Onyx Frontier |
| E.R. Squibb & Sons, L.L.C. | $216.85 | 2021-2025 | Eliquis, Camzyos |
| Amarin Pharma, INC. | $176.20 | 2019-2020 | |
| Pfizer INC. | $174.53 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $164.73 | 2020-2025 | Lifevest |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Awar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.